Sonexa Therapeutics' Series A - II Round

Sonexa Therapeutics raised a round of funding on April 19, 2010.

Sonexa Therapeutics is a clinical-stage biopharmaceutical company developing therapeutics for the treatment of Alzheimer's disease. ST101, the company's lead compound, represents an agent that, in ani…

Articles about Sonexa Therapeutics' Series A - II Round: